$PDEX
PRO DEX INC Stock $pdex

$pdex Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000107997324001462 Filed on October 31, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$14.89M	$11.94M
YoY Change		24.74%	7.68%
Cost Of Revenue		$9.742M	$8.280M
YoY Change		17.66%	1.83%
Gross Profit		$5.150M	$3.658M
YoY Change		40.79%	23.75%
Gross Profit Margin		34.58%	30.64%
Selling, General & Admin		$1.294M	$1.020M
YoY Change		26.86%	-5.29%
% of Gross Profit		25.13%	27.88%
Research & Development		$843.0K	$805.0K
YoY Change		4.72%	-13.35%
% of Gross Profit		16.37%	22.01%
Depreciation & Amortization		$302.0K	$282.0K
YoY Change		7.09%	46.11%
% of Gross Profit		5.86%	7.71%
Operating Expenses		$2.137M	$1.825M
YoY Change		17.1%	-9.02%
Operating Profit		$3.013M	$1.833M
YoY Change		64.38%	92.95%
Interest Expense		$152.0K	$133.0K
YoY Change		14.29%	2.31%
% of Operating Profit		5.04%	7.26%
Other Income/Expense, Net			-$2.662M
YoY Change			-873.84%
Pretax Income		$3.319M	-$829.0K
YoY Change		-500.36%	-164.06%
Income Tax		$853.0K	-$214.0K
% Of Pretax Income		25.7%
Net Earnings		$2.466M	-$615.0K
YoY Change		-500.98%	-157.16%
Net Earnings / Revenue		16.56%	-5.15%
Basic Earnings Per Share		$0.76	-$0.17
Diluted Earnings Per Share		$0.75	-$0.17
COMMON SHARES
Basic Shares Outstanding	3.259M shares	3.358M shares	3.547M shares
Diluted Shares Outstanding		3.292M shares	3.547M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.294M	$8.006M
YoY Change	16.09%	45.56%
Cash & Equivalents	$3.081M	$1.904M
Short-Term Investments	$6.213M	$6.102M
Other Short-Term Assets	$623.0K	$790.0K
YoY Change	-21.14%	-47.85%
Inventory	$16.60M	$16.26M
Prepaid Expenses
Receivables	$13.46M	$11.03M
Other Receivables	$0.00	$420.0K
Total Short-Term Assets	$38.50M	$31.42M
YoY Change	22.52%	-1.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.183M	$4.952M
YoY Change	4.66%	2.06%
Goodwill
YoY Change
Intangibles	$47.00K	$75.00K
YoY Change	-37.33%	-30.56%
Long-Term Investments	$1.475M	$5.090M
YoY Change	-71.02%	169.45%
Other Assets	$44.00K	$42.00K
YoY Change	4.76%	0.0%
Total Long-Term Assets	$15.81M	$18.16M
YoY Change	-12.97%	12.59%
TOTAL ASSETS
Total Short-Term Assets	$38.50M	$31.42M
Total Long-Term Assets	$15.81M	$18.16M
Total Assets	$54.31M	$49.59M
YoY Change	9.53%	3.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.442M	$2.740M
YoY Change	62.12%	-22.8%
Accrued Expenses	$4.019M	$2.701M
YoY Change	48.8%	-16.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.401M	$2.840M
YoY Change	-15.46%	-13.86%
Total Short-Term Liabilities	$11.29M	$8.281M
YoY Change	36.28%	-29.06%
LONG-TERM LIABILITIES
Long-Term Debt	$11.08M	$8.570M
YoY Change	29.32%	-13.63%
Other Long-Term Liabilities	$1.063M	$1.530M
YoY Change	-30.52%	-21.7%
Total Long-Term Liabilities	$12.15M	$10.11M
YoY Change	20.15%	-14.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.29M	$8.281M
Total Long-Term Liabilities	$12.15M	$10.11M
Total Liabilities	$23.43M	$18.39M
YoY Change	27.41%	-21.91%
SHAREHOLDERS EQUITY
Retained Earnings	$29.42M	$24.21M
YoY Change	21.51%	41.88%
Common Stock	$1.461M	$6.987M
YoY Change	-79.09%	-4.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$30.88M	$31.20M
YoY Change
Total Liabilities & Shareholders Equity	$54.31M	$49.59M
YoY Change	9.53%	3.38%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	$2.466M	-$615.0K
YoY Change	-500.98%	-157.16%
Depreciation, Depletion And Amortization	$302.0K	$282.0K
YoY Change	7.09%	46.11%
Cash From Operating Activities	$1.887M	$392.0K
YoY Change	381.38%	-86.45%
INVESTING ACTIVITIES
Capital Expenditures	$431.0K	$126.0K
YoY Change	242.06%	-29.21%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$431.0K	-$126.0K
YoY Change	242.06%	40.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.006M	-$1.298M
YoY Change	-22.5%	52.17%
NET CHANGE
Cash From Operating Activities	$1.887M	$392.0K
Cash From Investing Activities	-$431.0K	-$126.0K
Cash From Financing Activities	-$1.006M	-$1.298M
Net Change In Cash	$450.0K	-$1.032M
YoY Change	-143.6%	-152.95%
FREE CASH FLOW
Cash From Operating Activities	$1.887M	$392.0K
Capital Expenditures	$431.0K	$126.0K
Free Cash Flow	$1.456M	$266.0K
YoY Change	447.37%	-90.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000788920
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44000	usd
CY2024Q3	us-gaap	Assets Assets	54308000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4442000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4019000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2401000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1063000	usd
CY2024Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q3	pdex	Credit Loss Expense CreditLossExpense		usd
CY2023Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2023Q3	pdex	Payments Of Employee Taxes On Net Issuance Of Common Stock PaymentsOfEmployeeTaxesOnNetIssuanceOfCommonStock		usd
CY2023Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2024Q3	pdex	Massachusetts Income Tax Payments MassachusettsIncomeTaxPayments		usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2024Q3	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments		usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity File Number EntityFileNumber	0-14942
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	PRO-DEX, INC.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1261240
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	2361 McGaw Avenue
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Irvine
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92614
CY2024Q3	dei	City Area Code CityAreaCode	949
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	769-3200
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2024Q3	dei	Trading Symbol TradingSymbol	PDEX
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3259338	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3081000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2631000	usd
CY2024Q3	us-gaap	Short Term Investments ShortTermInvestments	4738000	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	4217000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3000	usd
CY2023Q3	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-43000	usd
CY2024Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4738000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4217000	usd
CY2024Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1475000	usd
CY2024Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1563000	usd
CY2024Q3	us-gaap	Marketable Securities MarketableSecurities	6213000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	5780000	usd
CY2024Q3	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	4000000.0	usd
CY2024Q2	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	4000000.0	usd
CY2024Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	2200000	usd
CY2024Q3	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	2700000	usd
CY2024Q3	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	518000	usd
CY2024	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1800000	usd
CY2024	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	2100000	usd
CY2024	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	261000	usd
CY2024Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	748000	usd
CY2024Q2	us-gaap	Other Short Term Investments OtherShortTermInvestments	987000	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	7438000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	6703000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3259742	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3546737	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3292142	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3546737	shares
CY2024Q3	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3297510	shares
CY2023Q3	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3547330	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	30867000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31590000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	30877000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	31195000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	2466000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-615000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	302000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	283000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	113000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	188000	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	433000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2553000	usd
CY2024Q3	pdex	Noncash Lease Recovery NoncashLeaseRecovery	-5000	usd
CY2023Q3	pdex	Noncash Lease Recovery NoncashLeaseRecovery	-2000	usd
CY2024Q3	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-10000	usd
CY2023Q3	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-4000	usd
CY2024Q3	pdex	Credit Loss Expense CreditLossExpense	3000	usd
CY2024Q3	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-51000	usd
CY2023Q3	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	97000	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1335000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13456000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13887000	usd
CY2024Q3	us-gaap	Deferred Costs Current DeferredCostsCurrent	211000	usd
CY2024Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	262000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	16604000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	15269000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	412000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	345000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	38502000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	36611000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6132000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6155000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5183000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5024000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1370000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1473000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	47000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	54000	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1555000	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1555000	usd
CY2024Q3	us-gaap	Long Term Investments LongTermInvestments	1475000	usd
CY2024Q2	us-gaap	Long Term Investments LongTermInvestments	1563000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	42000	usd
CY2024Q2	us-gaap	Assets Assets	52477000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4513000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3359000	usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	423000	usd
CY2024Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	632000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	14000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	4374000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11285000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	12892000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1182000	usd
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	11083000	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	7536000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12146000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8718000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	23431000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	21610000	usd
CY2024Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3297510	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3297510	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3363412	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3363412	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	1461000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	3917000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	29416000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	26950000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	30877000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	30867000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54308000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52477000	usd
CY2024Q3	us-gaap	Revenues Revenues	14892000	usd
CY2023Q3	us-gaap	Revenues Revenues	11938000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	9742000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	8280000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	5150000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	3658000	usd
CY2024Q3	us-gaap	Selling Expense SellingExpense	48000	usd
CY2023Q3	us-gaap	Selling Expense SellingExpense	25000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1246000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	995000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	843000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	805000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2137000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1825000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3013000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1833000	usd
CY2024Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	25000	usd
CY2023Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	24000	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	433000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2553000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	152000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	133000	usd
CY2024Q3	us-gaap	Other Income OtherIncome	306000	usd
CY2023Q3	us-gaap	Other Income OtherIncome	-2662000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3319000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-829000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	853000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-214000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	2466000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-615000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3259742	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3546737	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3292142	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3546737	shares
CY2024Q3	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3297510	shares
CY2023Q3	us-gaap	Weighted Average Number Of Limited Partnership And General Partnership Unit Outstanding Basic And Diluted WeightedAverageNumberOfLimitedPartnershipAndGeneralPartnershipUnitOutstandingBasicAndDiluted	3547330	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	30867000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31590000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	30877000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	31195000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	2466000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-615000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	302000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	283000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	113000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	188000	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	433000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2553000	usd
CY2024Q3	pdex	Noncash Lease Recovery NoncashLeaseRecovery	-5000	usd
CY2023Q3	pdex	Noncash Lease Recovery NoncashLeaseRecovery	-2000	usd
CY2024Q3	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-10000	usd
CY2023Q3	us-gaap	Amortization Of Deferred Loan Origination Fees Net AmortizationOfDeferredLoanOriginationFeesNet	-4000	usd
CY2024Q3	pdex	Credit Loss Expense CreditLossExpense	3000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-428000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1082000	usd
CY2024Q3	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-51000	usd
CY2023Q3	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	97000	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1335000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	97000	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	69000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-95000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	579000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	35000	usd
CY2024Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-209000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1887000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	392000	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	431000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	126000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-431000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-126000	usd
CY2024Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3427000	usd
CY2023Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1330000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4990000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	15000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	32000	usd
CY2024Q3	pdex	Payments Of Employee Taxes On Net Issuance Of Common Stock PaymentsOfEmployeeTaxesOnNetIssuanceOfCommonStock	273000	usd
CY2024Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2311000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1006000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1298000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	450000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1032000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2936000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3081000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1904000	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	162000	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	140000	usd
CY2024Q3	pdex	Federal Income Tax Payments FederalIncomeTaxPayments	690000	usd
CY2023Q3	pdex	Federal Income Tax Payments FederalIncomeTaxPayments	565000	usd
CY2024Q3	pdex	California Income Tax Payments CaliforniaIncomeTaxPayments	372000	usd
CY2023Q3	pdex	California Income Tax Payments CaliforniaIncomeTaxPayments	74000	usd
CY2023Q3	pdex	Massachusetts Income Tax Payments MassachusettsIncomeTaxPayments	21000	usd
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1062000	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	660000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	97000	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	69000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-95000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	579000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	35000	usd
CY2024Q3	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-14000	usd
CY2024Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-209000	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-873000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1887000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	392000	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	431000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	126000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-431000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-126000	usd
CY2024Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3427000	usd
CY2023Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1330000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4990000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	15000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	32000	usd
CY2024Q3	pdex	Payments Of Employee Taxes On Net Issuance Of Common Stock PaymentsOfEmployeeTaxesOnNetIssuanceOfCommonStock	273000	usd
CY2024Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2311000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1006000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1298000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	450000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1032000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2631000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2936000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3081000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1904000	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	162000	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	140000	usd
CY2024Q3	pdex	Federal Income Tax Payments FederalIncomeTaxPayments	690000	usd
CY2023Q3	pdex	Federal Income Tax Payments FederalIncomeTaxPayments	565000	usd
CY2024Q3	pdex	California Income Tax Payments CaliforniaIncomeTaxPayments	372000	usd
CY2023Q3	pdex	California Income Tax Payments CaliforniaIncomeTaxPayments	74000	usd
CY2023Q3	pdex	Massachusetts Income Tax Payments MassachusettsIncomeTaxPayments	21000	usd
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1062000	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	660000	usd
CY2024Q3	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_801_eus-gaap--NatureOfOperations_zcrkDgmwkgB2" style="font: bold 10pt Times New Roman, Times, Serif; margin: 8.1pt 0 10pt">NOTE 2. <span id="xdx_820_zbvgzEhjdPXl">DESCRIPTION OF BUSINESS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We specialize in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adaptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">In August 2020, we formed a wholly owned subsidiary, PDEX Franklin, LLC (“PDEX Franklin”), to hold title for an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”) that we acquired on November 6, 2020, in order to allow for the continued growth of our business. The condensed consolidated financial statements include the accounts of the Company and PDEX Franklin and all significant inter-company accounts and transactions have been eliminated. This subsidiary has no separate operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024Q3	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_801_eus-gaap--NatureOfOperations_zcrkDgmwkgB2" style="font: bold 10pt Times New Roman, Times, Serif; margin: 8.1pt 0 10pt">NOTE 2. <span id="xdx_820_zbvgzEhjdPXl">DESCRIPTION OF BUSINESS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We specialize in the design, development and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adaptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. We also manufacture and sell rotary air motors to a wide range of industries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in"><span style="letter-spacing: 0pt">In August 2020, we formed a wholly owned subsidiary, PDEX Franklin, LLC (“PDEX Franklin”), to hold title for an approximate 25,000 square foot industrial building in Tustin, California (the “Franklin Property”) that we acquired on November 6, 2020, in order to allow for the continued growth of our business. The condensed consolidated financial statements include the accounts of the Company and PDEX Franklin and all significant inter-company accounts and transactions have been eliminated. This subsidiary has no separate operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024Q3	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	47000	usd
CY2023Q3	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	190000	usd
CY2024Q3	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	14845000	usd
CY2023Q3	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	11748000	usd
CY2024Q3	us-gaap	Revenues Revenues	14892000	usd
CY2023Q3	us-gaap	Revenues Revenues	11938000	usd
CY2024Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	14000	usd
CY2023Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	262000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	494000	usd
CY2024Q3	us-gaap	Accretion Expense AccretionExpense	57000	usd
CY2023Q3	us-gaap	Accretion Expense AccretionExpense	219000	usd
CY2024Q3	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-102000	usd
CY2023Q3	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-105000	usd
CY2024Q3	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-6000	usd
CY2023Q3	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-17000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	211000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	591000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14000	usd
CY2023Q3	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	43000	usd
CY2024Q3	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-14000	usd
CY2023Q3	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-43000	usd
CY2024Q3	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	47000	usd
CY2023Q3	pdex	Overtime Revenue Recognition OvertimeRevenueRecognition	190000	usd
CY2024Q3	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	14845000	usd
CY2023Q3	pdex	Pointintime Revenue Recognition PointintimeRevenueRecognition	11748000	usd
CY2024Q3	us-gaap	Revenues Revenues	14892000	usd
CY2023Q3	us-gaap	Revenues Revenues	11938000	usd
CY2024Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	14000	usd
CY2023Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	262000	usd
CY2023Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	494000	usd
CY2024Q3	us-gaap	Accretion Expense AccretionExpense	57000	usd
CY2023Q3	us-gaap	Accretion Expense AccretionExpense	219000	usd
CY2024Q3	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-102000	usd
CY2023Q3	pdex	Amounts Reclassified To Cost Of Sales AmountsReclassifiedToCostOfSales	-105000	usd
CY2023Q3	pdex	Amounts Allocated To Discounts For Standalone Selling Price AmountsAllocatedToDiscountsForStandaloneSellingPrice	-17000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	211000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	591000	usd
CY2024Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14000	usd
CY2023Q3	us-gaap	Proceeds From Customers For Progress Payments ProceedsFromCustomersForProgressPayments	43000	usd
CY2024Q3	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-14000	usd
CY2023Q3	pdex	Amounts Reclassified To Revenue AmountsReclassifiedToRevenue	-43000	usd
CY2024Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4738000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4217000	usd
CY2024Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1475000	usd
CY2024Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1563000	usd
CY2024Q3	us-gaap	Marketable Securities MarketableSecurities	6213000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	5780000	usd
CY2024Q3	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	4000000.0	usd
CY2024Q2	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	4000000.0	usd
CY2024Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	2200000	usd
CY2024Q3	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	2700000	usd
CY2024Q3	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	518000	usd
CY2024	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1800000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4217000	usd
CY2024Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1475000	usd
CY2024Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	1563000	usd
CY2024Q3	us-gaap	Marketable Securities MarketableSecurities	6213000	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	5780000	usd
CY2024Q3	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	4000000.0	usd
CY2024Q2	pdex	Available For Sale Securities Amortized Costs AvailableForSaleSecuritiesAmortizedCosts	4000000.0	usd
CY2024Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	2200000	usd
CY2024Q3	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	2700000	usd
CY2024Q3	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	518000	usd
CY2024	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1800000	usd
CY2024	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	2100000	usd
CY2024	pdex	Marketable Securities Unrealized Loss MarketableSecuritiesUnrealizedLoss	261000	usd
CY2024Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	748000	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	7438000	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	5728000	usd
CY2024Q3	pdex	Inventory Sub Assemblies InventorySubAssemblies	2810000	usd
CY2024Q2	pdex	Inventory Sub Assemblies InventorySubAssemblies	2342000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	628000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1121000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	16604000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	15269000	usd
CY2024Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208000	usd
CY2024Q2	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-161000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-154000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47000	usd
CY2024	pdex	Marketable Securities Unrealized Gain MarketableSecuritiesUnrealizedGain	2100000	usd
CY2024Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	748000	usd
CY2024Q2	us-gaap	Other Short Term Investments OtherShortTermInvestments	987000	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	7438000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	6703000	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	5728000	usd
CY2024Q2	pdex	Inventory Sub Assemblies InventorySubAssemblies	2342000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	628000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	16604000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	15269000	usd
CY2024Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208000	usd
CY2024Q2	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-161000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-154000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	54000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	27000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	20000	usd
CY2024Q3	pdex	Product Warranty Reserve ProductWarrantyReserve	300000	usd
CY2024Q2	pdex	Product Warranty Reserve ProductWarrantyReserve	277000	usd
CY2024Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	277000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	200000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	90000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	24000	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	5728000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	5103000	usd
CY2024Q3	pdex	Inventory Sub Assemblies InventorySubAssemblies	2810000	usd
CY2024Q2	pdex	Inventory Sub Assemblies InventorySubAssemblies	2342000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	628000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1121000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	16604000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	15269000	usd
CY2024Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208000	usd
CY2024Q2	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	208000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-154000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	47000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	54000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	20000	usd
CY2024Q3	pdex	Product Warranty Reserve ProductWarrantyReserve	300000	usd
CY2024Q2	pdex	Product Warranty Reserve ProductWarrantyReserve	277000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	200000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	90000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	24000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-18000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-2000	usd
CY2024Q3	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	-49000	usd
CY2023Q3	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	-33000	usd
CY2024Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	300000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	189000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	54000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	27000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	20000	usd
CY2024Q3	pdex	Product Warranty Reserve ProductWarrantyReserve	300000	usd
CY2024Q2	pdex	Product Warranty Reserve ProductWarrantyReserve	277000	usd
CY2024Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	277000	usd
CY2023Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	200000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	90000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	24000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-18000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-2000	usd
CY2024Q3	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	-49000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	189000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2466000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-615000	usd
CY2024Q3	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3260	shares
CY2023Q3	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3547	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2466000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-615000	usd
CY2024Q3	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3260	shares
CY2024Q3	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3292	shares
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2024Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	71000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	6000	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	7000	usd
CY2024Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-18000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-2000	usd
CY2024Q3	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	-49000	usd
CY2023Q3	pdex	Product Warranty Accrual Amortization ProductWarrantyAccrualAmortization	-33000	usd
CY2024Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	300000	usd
CY2023Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	189000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2466000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-615000	usd
CY2024Q3	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3260	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2466000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-615000	usd
CY2024Q3	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3260	shares
CY2023Q3	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3547	shares
CY2024Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	32	shares
CY2024Q3	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3292	shares
CY2023Q3	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3547	shares
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2024	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	71000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	6000	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	7000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.26	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.26	pure
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2466000	usd
CY2024Q3	pdex	Weightedaverage Shares Outstanding Basic WeightedaverageSharesOutstandingBasic	3260	shares
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2466000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-615000	usd
CY2024Q3	pdex	Weightedaverage Shares Outstanding Diluted WeightedaverageSharesOutstandingDiluted	3260	shares
CY2024Q3	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3292	shares
CY2023Q3	pdex	Weighted Average Shares Used In Calculation Of Diluted Earnings Per Share WeightedAverageSharesUsedInCalculationOfDilutedEarningsPerShare	3547	shares
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2024Q3	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	71000	usd
CY2024	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	71000	usd
CY2024Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	6000	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	7000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.26	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.26	pure
CY2024Q3	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.26	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation Beat Percent EffectiveIncomeTaxRateReconciliationBeatPercent	0.26	pure
CY2024Q2	us-gaap	Notes Payable NotesPayable	11956000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	466000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0553	pure
CY2024Q3	us-gaap	Notes Payable NotesPayable	13529000	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	11956000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	466000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0553	pure
CY2024Q3	us-gaap	Utilities Operating Expense Maintenance UtilitiesOperatingExpenseMaintenance	41000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	404000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	551000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	567000	usd
CY2024Q3	us-gaap	Notes Payable NotesPayable	13529000	usd
CY2024Q2	us-gaap	Notes Payable NotesPayable	11956000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	466000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0553	pure
CY2024Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	130000	usd
CY2024Q3	us-gaap	Utilities Operating Expense Maintenance UtilitiesOperatingExpenseMaintenance	41000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	404000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	551000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	567000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	143000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	136000	usd
CY2024Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	130000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	404000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	551000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	567000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	143000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1665000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	136000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1529000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	143000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1665000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	136000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1529000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001079973-24-001462-index-headers.html	Edgar Link	pending
0001079973-24-001462-index.html	Edgar Link	pending
0001079973-24-001462.txt	Edgar Link	pending
0001079973-24-001462-xbrl.zip	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pdex-20240930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pdex_10q-093024.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
pdex-20240930_def.xml	Edgar Link	unprocessable
pdex-20240930_lab.xml	Edgar Link	unprocessable
pdex-20240930_pre.xml	Edgar Link	unprocessable
pdex_10q-093024_htm.xml	Edgar Link	completed
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pdex-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PDEX
PRO DEX INC Stock $pdex

2024 Q4 Form 10-Q Financial Statement

#000107997324001462 Filed on October 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX PRO DEX INC Stock $pdex

2024 Q4 Form 10-Q Financial Statement

#000107997324001462 Filed on October 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PDEX
PRO DEX INC Stock $pdex